Date:
August 05, 2026
Content:
The U.S. Food and Drug Administration (FDA) has updated its records regarding C.A.T. Gmbh and Co. KG, a manufacturing entity based in Tübingen, Germany. This update serves as part of the agency’s ongoing transparency initiative regarding international facility inspections and compliance history.
Registered under the FDA Establishment Identifier (FEI) 3004422881, the firm has been subject to regulatory oversight dating back to March 2012. The publication of these records ensures that the medical and pharmaceutical supply chains remain accountable to established safety standards for products entering the United States.
The FDA maintains these compliance profiles to monitor the adherence of foreign manufacturers to Good Manufacturing Practices (GMP). Stakeholders are encouraged to review the specific details of the firm’s history to ensure that all imported goods meet the rigorous quality requirements mandated by federal law.
Source: FDA Official Update
Link:
http://www.fda.gov/about-fda/cat-gmbh-and-co-kg
Keywords:
FDA, C.A.T. Gmbh and Co. KG, Regulatory Compliance, Germany, Manufacturing Oversight